EGFR and neoplasm: Single-cell analysis showed that the simple coexistence of EGFR mut and EGFR wt cells within the tumor may attenuate the response to EGFR TKI, since only tumor cells harboring EGFR sensitizing mutations display responsiveness to TKI treatments.